We have experience across more than six major therapeutic areas, including oncology, infectious diseases, respiratory conditions, endocrine and metabolic disorders, cardiovascular disease, women’s health, urology, and rare diseases.
We are able to expand into new therapeutic areas as required by the study.
Our team is always here to help.
If you have questions about eligibility, safety, or the study process, please contact our research staff at any time.
Every study is reviewed and approved by an Independent Review Board (IRB).
The IRB ensures:
The IRB continues oversight throughout the entire study.
Only authorized BioPartners clinical staff can access your identifiable information.
Any data or samples shared with researchers or sponsors are de-identified — meaning they cannot be traced back to you.
Your privacy is always protected.
